Bioclassifier NanoString Plans to Take Second-Gen nCounter Technology through FDA Premium By Justin Petrone NanoString to Launch New Expression Assays; CEO Dishes on Dx Strategy Premium This story has been updated from a previous version to include information about a competitive offering. By Justin Petrone NanoString Says New PAM50 Studies Confirm Assay's Clinical Validity Premium The quintet of studies, presented at the American Society of Clinical Oncology annual meeting last week, could help support NanoString's diagnostic ambitions. Dx Focus Jan 20, 2011: Clinical and Regulatory PCR and Nucleic Acid Testing News Premium ARUP Labs launches PAM50 Breast Cancer Intrinsic Classifier. NanoString Developing Genomic Test to Gauge Benefit of Chemo Classes for Breast Cancer Premium NanoString is betting that its test will predict treatment benefit for specific classes of chemotherapies, which will differentiate it from other genomic breast cancer tests on the market. Dec 9, 2010 Bioclassifier, NanoString to 'Decentralize' Breast Cancer Test as ARUP Preps qPCR Version Premium Dec 7, 2010 NanoString Technologies Hopes to Achieve FDA Clearance for Breast Cancer Test by 2012 Premium Dec 7, 2010 NanoString Licenses Bioclassifier Technology Breaking News Children With Autism May Have Underdeveloped Gut Microbiomes, Metagenomic Analysis Finds Kiromic BioPharma Acquires InSilico Solutions Bio-Rad Laboratories, 10x Genomics Settle IP Lawsuits, Sign Global Cross-Licensing Agreement Scope Fluidics Obtains CE Mark for PCR-Based SARS-CoV-2 Panel MeMed COVID-19 Prognostic Test Receives CE Mark ERS Genomics Licenses CRISPR IP to Japan SLC The Scan Dropped Charges The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal. More Kids The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children. PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more. Purnell Choppin Dies Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.